1. Home
  2. VNDA vs TG Comparison

VNDA vs TG Comparison

Compare VNDA & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TG
  • Stock Information
  • Founded
  • VNDA 2002
  • TG 1988
  • Country
  • VNDA United States
  • TG United States
  • Employees
  • VNDA N/A
  • TG N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • VNDA Health Care
  • TG Industrials
  • Exchange
  • VNDA Nasdaq
  • TG Nasdaq
  • Market Cap
  • VNDA 237.9M
  • TG 264.1M
  • IPO Year
  • VNDA 2006
  • TG 1989
  • Fundamental
  • Price
  • VNDA $4.22
  • TG $8.27
  • Analyst Decision
  • VNDA Strong Buy
  • TG
  • Analyst Count
  • VNDA 2
  • TG 0
  • Target Price
  • VNDA $16.50
  • TG N/A
  • AVG Volume (30 Days)
  • VNDA 500.0K
  • TG 69.5K
  • Earning Date
  • VNDA 05-07-2025
  • TG 05-08-2025
  • Dividend Yield
  • VNDA N/A
  • TG N/A
  • EPS Growth
  • VNDA N/A
  • TG N/A
  • EPS
  • VNDA N/A
  • TG N/A
  • Revenue
  • VNDA $201,351,000.00
  • TG $617,823,000.00
  • Revenue This Year
  • VNDA $14.36
  • TG N/A
  • Revenue Next Year
  • VNDA $44.53
  • TG N/A
  • P/E Ratio
  • VNDA N/A
  • TG N/A
  • Revenue Growth
  • VNDA 13.37
  • TG 17.42
  • 52 Week Low
  • VNDA $3.85
  • TG $4.31
  • 52 Week High
  • VNDA $6.75
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 41.17
  • TG 63.47
  • Support Level
  • VNDA $4.20
  • TG $7.67
  • Resistance Level
  • VNDA $4.64
  • TG $8.20
  • Average True Range (ATR)
  • VNDA 0.17
  • TG 0.30
  • MACD
  • VNDA 0.01
  • TG 0.10
  • Stochastic Oscillator
  • VNDA 20.75
  • TG 79.05

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: